The ₹100-crore buyback offer from Eris Lifesciences will open on Wednesday and close on January 15, 2020. Eris plans to buy back up to 17.39 lakh shares (being about 1.26 per cent of the total paid-up equity capital of the company) at ₹575 a share. As the buyback will be on proportionate basis through the tender offer route, only those shareholders whose names had appeared on the company’s books on July 19 (record date) are eligible to participate in the offer.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.